Upload Avatar (500 x 500)
Dongfang Wu
dfwu2003@163.com
Chinese, English
Hubei
Wuhan University
Medical School
  • 1982.9 - 1987.7 Bachelor of Medicine: Hubei Medical College
  • 1990.9 - 1993.7 Master of Medicine in Pharmacology: Hubei Medical University
  • 2001.9 - 2005.12 PhD in Pharmacology: Wuhan University
  • 2008.3 - Present: Wuhan University Zhongnan Hospital, Department of Pharmacy
  • 2003.7 - 2007.10: Meharry Medical College, Department of Cardiovascular Biology, USA
  • 2002.7 - 2002.10: University of Nancy, School of Pharmacy, France
  • 1993.7 - 2008.2: Wuhan University People's Hospital, Department of Pharmacy
  • 1987.7 - 1990.9: Wuhan Metallurgical Medical College, Department of Pharmacology
  • 2003: National New Drug Certificate for Lactate Levofloxacin Eye Drops (Main Contributor)
  • 2000: Hubei Province Natural Science Third Prize for the hepatoprotective action of Sodium Ferulate (Third Place)
  • 2000: Hubei Province Health Science and Technology Progress Third Prize for 'Clinical Drug Therapy' (Fourth Place)
Pharmacology
  • 2-Aminopurine inhibits lipid accumulation induced by apolipoprotein E-deficient lipoprotein in macrophages: potential role eukaryotic initiation factor-2 alpha phosphorylation in foam cell formation, Dongfang Wu, Hong Yang, Yanfeng Zhao, et al., 2008
  • Apolipoprotein E-deficient lipoprotein induce foam cell formation by downregulation of lysosomal hydrolases in macrophages, Dongfang Wu, Chakradhari Sharan, Hong Yang, et al., 2007
Atherosclerosis Molecular Mechanisms Drug Intervention Clinical Pharmacology Lipid Metabolism Foam Cell Formation Lysosomal Hydrolases Apolipoprotein E-Deficient Macrophages Eukaryotic Initiation Factor

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.